SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?


To: fred hayes who wrote (9941)9/22/2008 10:02:34 AM
From: Lee39  Respond to of 10345
 
Biogen put out an PR
biogenidec.com
"Patients on TYSABRI therapy have continued to increase."

Since they didn't state how many patients now on therapy, the new prescriptions rate probably dropped since the new PML cases announcements.